Enhanced Antibiofilm Activity of Copper Nanoparticles Stabilized With Polyvinyl Pyrrolidone and Polyvinyl Alcohol Against Pseudomonas aeruginosa and Staphylococcus aureus

IF 3.4 4区 医学 Q2 ENGINEERING, BIOMEDICAL
Imzazul Rahaman, Namita Srivastava, Damini Thakur, Anshul Jamwal, Lokender Kumar
{"title":"Enhanced Antibiofilm Activity of Copper Nanoparticles Stabilized With Polyvinyl Pyrrolidone and Polyvinyl Alcohol Against Pseudomonas aeruginosa and Staphylococcus aureus","authors":"Imzazul Rahaman,&nbsp;Namita Srivastava,&nbsp;Damini Thakur,&nbsp;Anshul Jamwal,&nbsp;Lokender Kumar","doi":"10.1002/jbm.b.35633","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p><i>Pseudomonas aeruginosa</i> and <i>Staphylococcus aureus</i> are biofilm-forming pathogens that contribute to persistent infections and exhibit high resistance to conventional antibiotics. In the present study, copper nanoparticles (Cu-NPs) were synthesized using polyvinylpyrrolidone (PVP) and polyvinyl alcohol (PVA) as polymeric stabilizing agents to evaluate their potential in biofilm inhibition. The synthesized Cu-NPs were characterized by Ultraviolet–Visible (UV–Vis) spectroscopy, Fourier-Transform Infrared (FT-IR) spectroscopy, Dynamic Light Scattering (DLS), zeta potential, Field Emission Scanning Electron Microscopy (FE-SEM), Energy-Dispersive X-ray spectroscopy (EDS), and X-ray diffraction (XRD). The average particle sizes of the two formulations were found to be ~114 nm (PVP-Cu-NP) and ~127 nm (PVA-Cu-NP). Both NPs have demonstrated strong biofilm inhibitory activity at sub-minimum inhibitory concentrations (Sub-MICs) up till Day 3. The inhibitory efficacy of PVP-NP and PVA-NP against <i>P. aeruginosa</i> biofilm was 59.4% and 73.10%, respectively. Whereas the inhibitory efficacy of the two formulations against <i>S. aureus</i> biofilm was found to be 78.94% by PVP-NP and 88.94% by PVA-NP. Additionally, the Sub-MIC concentrations of PVP-NP and PVA-NP significantly reduced cell surface hydrophobicity (CSH) and exopolysaccharide (EPS) production, thereby disrupting key components of biofilm architecture. These findings suggest that polymer-stabilized copper nanoparticles may provide promising therapeutic strategies for the prevention and control of biofilm-forming and antibiotic-resistant disease-causing pathogens.</p>\n </div>","PeriodicalId":15269,"journal":{"name":"Journal of biomedical materials research. Part B, Applied biomaterials","volume":"113 8","pages":""},"PeriodicalIF":3.4000,"publicationDate":"2025-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of biomedical materials research. Part B, Applied biomaterials","FirstCategoryId":"5","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jbm.b.35633","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0

Abstract

Pseudomonas aeruginosa and Staphylococcus aureus are biofilm-forming pathogens that contribute to persistent infections and exhibit high resistance to conventional antibiotics. In the present study, copper nanoparticles (Cu-NPs) were synthesized using polyvinylpyrrolidone (PVP) and polyvinyl alcohol (PVA) as polymeric stabilizing agents to evaluate their potential in biofilm inhibition. The synthesized Cu-NPs were characterized by Ultraviolet–Visible (UV–Vis) spectroscopy, Fourier-Transform Infrared (FT-IR) spectroscopy, Dynamic Light Scattering (DLS), zeta potential, Field Emission Scanning Electron Microscopy (FE-SEM), Energy-Dispersive X-ray spectroscopy (EDS), and X-ray diffraction (XRD). The average particle sizes of the two formulations were found to be ~114 nm (PVP-Cu-NP) and ~127 nm (PVA-Cu-NP). Both NPs have demonstrated strong biofilm inhibitory activity at sub-minimum inhibitory concentrations (Sub-MICs) up till Day 3. The inhibitory efficacy of PVP-NP and PVA-NP against P. aeruginosa biofilm was 59.4% and 73.10%, respectively. Whereas the inhibitory efficacy of the two formulations against S. aureus biofilm was found to be 78.94% by PVP-NP and 88.94% by PVA-NP. Additionally, the Sub-MIC concentrations of PVP-NP and PVA-NP significantly reduced cell surface hydrophobicity (CSH) and exopolysaccharide (EPS) production, thereby disrupting key components of biofilm architecture. These findings suggest that polymer-stabilized copper nanoparticles may provide promising therapeutic strategies for the prevention and control of biofilm-forming and antibiotic-resistant disease-causing pathogens.

聚乙烯吡咯烷酮和聚乙烯醇稳定的铜纳米颗粒对铜绿假单胞菌和金黄色葡萄球菌的抗膜活性增强
铜绿假单胞菌和金黄色葡萄球菌是形成生物膜的病原体,有助于持续感染,并对传统抗生素表现出高度耐药性。本研究以聚乙烯吡咯烷酮(PVP)和聚乙烯醇(PVA)为高分子稳定剂,合成了铜纳米粒子(Cu-NPs),考察了它们在生物膜抑制中的潜力。采用紫外-可见(UV-Vis)光谱、傅里叶变换红外(FT-IR)光谱、动态光散射(DLS)、ζ电位、场发射扫描电镜(FE-SEM)、能量色散x射线能谱(EDS)和x射线衍射(XRD)对合成的Cu-NPs进行了表征。两种配方的平均粒径分别为~114 nm (PVP-Cu-NP)和~127 nm (PVP-Cu-NP)。直到第3天,这两种NPs在亚最低抑制浓度(sub- mic)下都表现出很强的生物膜抑制活性。PVP-NP和PVA-NP对铜绿假单胞菌生物膜的抑制率分别为59.4%和73.10%。而PVP-NP和PVA-NP对金黄色葡萄球菌生物膜的抑制效果分别为78.94%和88.94%。此外,亚mic浓度的PVP-NP和PVA-NP显著降低了细胞表面疏水性(CSH)和胞外多糖(EPS)的产生,从而破坏了生物膜结构的关键成分。这些发现表明,聚合物稳定的铜纳米颗粒可能为预防和控制生物膜形成和耐药致病菌提供有前途的治疗策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
7.50
自引率
2.90%
发文量
199
审稿时长
12 months
期刊介绍: Journal of Biomedical Materials Research – Part B: Applied Biomaterials is a highly interdisciplinary peer-reviewed journal serving the needs of biomaterials professionals who design, develop, produce and apply biomaterials and medical devices. It has the common focus of biomaterials applied to the human body and covers all disciplines where medical devices are used. Papers are published on biomaterials related to medical device development and manufacture, degradation in the body, nano- and biomimetic- biomaterials interactions, mechanics of biomaterials, implant retrieval and analysis, tissue-biomaterial surface interactions, wound healing, infection, drug delivery, standards and regulation of devices, animal and pre-clinical studies of biomaterials and medical devices, and tissue-biopolymer-material combination products. Manuscripts are published in one of six formats: • original research reports • short research and development reports • scientific reviews • current concepts articles • special reports • editorials Journal of Biomedical Materials Research – Part B: Applied Biomaterials is an official journal of the Society for Biomaterials, Japanese Society for Biomaterials, the Australasian Society for Biomaterials, and the Korean Society for Biomaterials. Manuscripts from all countries are invited but must be in English. Authors are not required to be members of the affiliated Societies, but members of these societies are encouraged to submit their work to the journal for consideration.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信